- JP-listed companies
- Income statement
【JP:3417】Income statement
Market cap
¥19B
P/E ratio
Oki Healthcare Holdings manages a pharmaceutical group of eight companies that manufacture and sell medicines and related products for the healthcare industry.
| 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Revenue | 207,593 | 222,342 | 239,531 | 258,481 | 277,260 | 286,173 | 278,162 | 304,445 | 334,661 | 349,452 |
| Revenue growth (%) | - | |||||||||
| Cost of revenue | 187,280 | 200,348 | 215,284 | 232,582 | 249,345 | 256,584 | 264,437 | 288,563 | 317,460 | 330,942 |
| Gross profit | 20,313 | 21,993 | 24,247 | 25,898 | 27,914 | 29,589 | 13,725 | 15,882 | 17,200 | 18,510 |
| Gross margin (%) | ||||||||||
| Operating margin (%) | ||||||||||
| Operating expenses | 19,703 | 20,694 | 21,903 | 23,863 | 25,674 | 26,579 | 13,093 | 13,822 | 15,157 | 15,741 |
| Operating income | 609 | 1,298 | 2,344 | 2,035 | 2,240 | 3,010 | 631 | 2,059 | 2,042 | 2,768 |
| Income before tax | 1,472 | 2,208 | 3,295 | 3,124 | 3,203 | 4,106 | 1,583 | 3,153 | 3,259 | 3,991 |
| Pretax margin (%) | 0.7 | 1 | 1.4 | 1.2 | 1.2 | 1.4 | 0.6 | 1 | 1 | 1.1 |
| Provision for income taxes | 847 | 584 | 914 | 969 | 897 | 1,231 | 605 | 998 | 1,278 | 1,188 |
| Effective tax rate (%) | ||||||||||
| Net income | 742 | 759 | 2,315 | 2,081 | 2,434 | 2,892 | 972 | 2,183 | 2,210 | 2,643 |
| Net income margin (%) | ||||||||||
| Earnings per share | 53.85 | 54.38 | 165 | 146.54 | 170.7 | 202.73 | 70.51 | 158.22 | 160.45 | 193.49 |
| Dividend per share | - | - | - | - | 19 | 20 | 21 | 22 | 24 | 26 |
| EBITDA | ||||||||||
| EBITDA margin (%) |